Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

Globus Medical GMED has outperformed the market over the past 10 years by 1.79% on an annualized basis producing an average annual return of 12.81%. Currently, Globus Medical has a market ...

Globus Medical GMED has outperformed the market over the past 10 years by 1.83% on an annualized basis producing an average ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to ...

Three of IUSG's underlying holdings with notable upside to their analyst target prices are Kirby Corp. (Symbol: KEX), Belden Inc (Symbol: BDC), and Globus Medical Inc (Symbol: GMED). Although KEX ...

Charles Schwab Investment Management Inc. lowered its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.4% in the fourth quarter, according to the company in its most recent disclosure ...

For the quarter ended December 2024, Globus Medical (GMED) reported revenue of $657.29 million, up 6.6% over the same period last year. EPS came in at $0.84, compared to $0.60 in the year-ago quarter.

AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of the ...

Wall Street analysts expect Globus Medical (GMED) to post quarterly earnings of $0.76 per share in its upcoming report, which indicates a year-over-year increase of 26.7%. Revenues are expected to ...